EARNINGS (LOSS) PER COMMON SHARE

3 Months Ended

Mar. 31, 2024

The computation of basic and diluted earnings (loss) per common share for the three months ended March 31, 2024 and 2023 was as follows:


Basic Earnings (Loss) Per Common Share	Three Months Ended
(in millions, except per share amounts)	2024		2023

Net income (loss) attributable to Dentsply Sirona	$	18	$	(19)

Weighted average common shares outstanding	207.4		214.5

Earnings (loss) per common share - basic	$	0.09	$	(0.09)

Diluted Earnings (Loss) Per Common Share	Three Months Ended
(in millions, except per share amounts)	2024		2023

Net income (loss) attributable to Dentsply Sirona	$	18	$	(19)

Weighted average common shares outstanding	207.4		214.5
Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards	1.1		—
Total weighted average diluted shares outstanding	208.5		214.5

Earnings (loss) per common share - diluted	$	0.09	$	(0.09)

Weighted average shares excluded from diluted common shares outstanding due to reported net loss for the period	—		1.4

Weighted average shares excluded from diluted common shares outstanding due to antidilutive nature	3.3		3.8

On November 7, 2023, the Board of Directors approved an increase to the authorized share repurchase program of $1.0 billion. Share repurchases may be made through open market purchases, Rule 10b5-1 plans, accelerated share repurchases, privately negotiated transactions or other transactions in such amounts and at such times as the Company considers appropriate based upon prevailing market and business conditions and other factors. At March 31, 2024, the Company had authorization to repurchase $1.44 billion in shares of common stock remaining under the share repurchase program.